FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 and 17

Novavax announced on Saturday that its Covid-19 vaccine has been authorized for emergency use by the FDA for adolescents between the ages of 12 and 17.

from US Top News and Analysis https://ift.tt/CX7FvKc
https://ift.tt/VKHgh6r